Aristada is a prescription medication used to treat schizophrenia [1]. It is an atypical antipsychotic developed by Alkermes [1][2].
How does Aristada work?
Aristada's active ingredient is aripiprazole lauroxil, an extended-release injectable formulation of aripiprazole [1][3]. Aripiprazole is believed to work by affecting the activity of dopamine and serotonin in the brain, which are neurotransmitters that play a role in mood, behavior, and thought processes [1][4].
What are the different Aristada formulations?
Aristada is available in several extended-release intramuscular injection formulations. These include once-monthly and every-two-month injections [1][5].
When does Aristada's patent expire?
Information regarding the specific patent expiry dates for Aristada is available through resources like DrugPatentWatch.com [6]. Patent expiry dictates when generic versions of a drug can be manufactured and marketed.
Who manufactures Aristada?
Alkermes is the company that developed and manufactures Aristada [1][2].
What are the potential side effects of Aristada?
Common side effects of Aristada can include injection site reactions, insomnia, headache, and weight gain [1]. More serious side effects may occur, and patients should discuss these with their healthcare provider.
What clinical trials have been conducted for Aristada?
Alkermes has conducted clinical trials to evaluate the efficacy and safety of Aristada for schizophrenia [7]. These trials typically involve comparing the drug to placebo or other treatments and monitoring patient outcomes and adverse events.